BWFA
AGN

Baltimore-Washington Financial Advisors’s Allergan plc AGN Stock Holding History

Baltimore-Washington Financial Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-37
Closed -$10K – 275
2015
Q3 		$10K Buy
+37
New +$11.4K ﹤0.01% 195

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Baltimore-Washington Financial Advisors's AGN Position: Q4 2015 in Review

Baltimore-Washington Financial Advisors sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 37 shares — an estimated $10K sold.

Baltimore-Washington Financial Advisors first reported a position in AGN in Q3 2015 and held it in 1 quarter. The position peaked at $10K in Q3 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Baltimore-Washington Financial Advisors reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
  • Baltimore-Washington Financial Advisors sold 37 Allergan plc shares in Q4 2015, an estimated $10K.
  • Baltimore-Washington Financial Advisors first reported a position in Allergan plc in Q3 2015 and held it in 1 quarter.
  • Baltimore-Washington Financial Advisors's Allergan plc position peaked at $10K in Q3 2015.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q4 2015, filed 1 Feb 2016.